Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long …
G Helbig, B Stella-Holowiecka, J Wojnar… - Annals of …, 2007 - Springer
Blood group incompatibility between donor and recipient of allogeneic stem cell transplants
may be associated with post-transplant erythroid aplasia. A total of 548 patients (pts) …
may be associated with post-transplant erythroid aplasia. A total of 548 patients (pts) …
Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study
T Longval, JE Galimard, AC Leprêtre… - British Journal of …, 2021 - Wiley Online Library
Pure red cell aplasia (PRCA) following allogeneic haematopoietic stem cell transplantation
(aHSCT) with major ABO incompatibility is responsible for transfusion dependent anaemia …
(aHSCT) with major ABO incompatibility is responsible for transfusion dependent anaemia …
Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question
J Marco-Ayala, I Gómez-Seguí, G Sanz… - Bone marrow …, 2021 - nature.com
Pure red cell aplasia (PRCA) is a complication related to major or bidirectional ABO
mismatched hematopoietic stem cell transplantation. This disorder is characterized by …
mismatched hematopoietic stem cell transplantation. This disorder is characterized by …
[HTML][HTML] Pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplantation is associated with severe pancytopenia
FM Aung, B Lichtiger, G Rondon, CC Yin… - Biology of Blood and …, 2016 - Elsevier
In major ABO-mismatched allogeneic hematopoietic stem cell transplantation (HSCT)
persistence of antidonor isohemagglutinins leads to pure red cell aplasia (PRCA). To …
persistence of antidonor isohemagglutinins leads to pure red cell aplasia (PRCA). To …
[HTML][HTML] Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors
M Hirokawa, T Fukuda, K Ohashi, M Hidaka… - Biology of Blood and …, 2013 - Elsevier
No standard of care for pure red cell aplasia (PRCA) after major ABO-incompatible
hematopoietic stem cell transplantation (HSCT) has been established. We conducted a …
hematopoietic stem cell transplantation (HSCT) has been established. We conducted a …
Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation
UR Deotare, A Vishwabandya, V Mathews… - Bone marrow …, 2006 - nature.com
We report a case of pure red cell aplasia (PRCA) following allogeneic peripheral blood stem
cell transplantation (PBSCT) for aplastic anemia with major ABO mismatch that proved …
cell transplantation (PBSCT) for aplastic anemia with major ABO mismatch that proved …
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation
K Zhu, J Li, T Zhang, J Zhong, J Chen - Hematology, 2007 - Taylor & Francis
The objective of this paper was to study the incidence, risk factors, clinical outcome,
management and prevention of pure red cell aplasia (PRCA) following major ABO …
management and prevention of pure red cell aplasia (PRCA) following major ABO …
Efficacy of plasmapheresis for the treatment of pure red blood cell aplasia after allogeneic stem cell transplantation
CM Dellacasa, S D'Ardia, B Allione, S Aydin… - …, 2015 - Wiley Online Library
BACKGROUND Pure red blood cell aplasia (PRCA) is a complication of ABO major‐
incompatible stem cell transplantation, likely due to the persistence of memory B …
incompatible stem cell transplantation, likely due to the persistence of memory B …
Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib
LM Poon, LP Koh - Bone marrow transplantation, 2012 - nature.com
Pure red cell aplasia (PRCA) is a rare but well-recognized immunohematological
complication that occurs in the setting of major ABO-incompatible hematopoietic stem cell …
complication that occurs in the setting of major ABO-incompatible hematopoietic stem cell …
[HTML][HTML] Prevalence of pure red cell aplasia following major ABO-incompatible hematopoietic stem cell transplantation
P Zhu, Y Wu, D Cui, J Shi, J Yu, Y Zhao, X Lai… - Frontiers in …, 2022 - frontiersin.org
Background Pure red cell aplasia (PRCA) is one of the important complications in major
ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT). The …
ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT). The …